Rethinking high-risk neuroblastoma treatment

Pediatr Blood Cancer. 2022 Aug;69(8):e29730. doi: 10.1002/pbc.29730. Epub 2022 Apr 20.

Authors

Susan L Cohn¹, Andrew D J Pearson²

Affiliations

¹ Section of Pediatric Hematology and Oncology, Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
² Division of Clinical Studies, Institute of Cancer Research, Royal Marsden Hospital, (retired), Sutton, UK.

PMID: 35441788
DOI: 10.1002/pbc.29730

No abstract available

Publication types

Comment

MeSH terms

Disease-Free Survival
Humans
Neuroblastoma* / drug therapy